查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591894

人體肝臟模型市場：按產品和應用分類的全球預測 - 2025-2030

Human Liver Model Market by Product (2D Models, 3D Bio Printing, Liver Organoids), Application (Drug Discovery, Education) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年人類肝臟模型市值為22.6億美元，預計到2024年將達到25.3億美元，複合年成長率為12.06%，到2030年將達到50.3億美元。

人體肝臟模型市場包括開發和利用模擬肝功能用於研究和治療目的的體外和體內模型。這些模型對於藥物發現、臨床前測試和毒理學研究至關重要，因為它們可以模擬人類肝臟反應，並可以減少對動物實驗的依賴。肝臟疾病盛行率的上升，特別是由於消費量、肥胖和病毒感染的增加，推動了對人類肝臟模型的需求。此外，製藥和生物技術行業大量使用這些模型來加速藥物開發流程並評估肝毒性風險。最終用途包括製藥、生物技術公司和醫療保健部門，研究人員包括學術研究、臨床試驗和再生醫學。

主要市場統計
基準年[2023] 22.6億美元
預測年份 [2024] 25.3億美元
預測年份 [2030] 50.3億美元
複合年成長率（%） 12.06%

市場成長主要受到生物技術進步的影響，例如 3D 生物列印和晶片器官技術，這些技術提供了更準確和功能性的肝臟模型。此外，隨著擴大採用人類肝臟模型，減少動物試驗的監管支持也不斷增加。個人化醫療和精準醫療保健的擴展存在潛在的商機，肝臟模型可以提供量身定做的治療測試。公司應該專注於提高這些模型的生理有效性，並投資於提高可擴展性和可重複性的技術。

儘管具有潛力，但人類肝臟模型市場面臨初始投資成本高、模型準確性方面的技術挑戰以及體外捕獲所有肝功能的複雜性等限制。此外，智慧財產權和嚴格的監管標準可能對進入和創新構成重大障礙。為了刺激業務成長，研究應著重於改善組織培養和整合人工智慧進行預測分析。與監管機構的持續合作以及對跨學科研究的投資可以進一步放大市場潛力。儘管市場競爭激烈，但提高模型可靠性和適用性的創新時機已經成熟，為擁有尖端解決方案的新進業者提供了沃土。

市場動態：快速發展的人類肝臟模型市場的關鍵市場洞察

人類肝臟模型市場正在因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 非酒精性脂肪肝盛行率上升
    • 人類肝臟疾病體外建模的新興 3D 和 2D 趨勢
    • 對肝臟類器官的努力和不斷提高的認知
  • 市場限制因素
    • 缺乏熟練且訓練有素的專業人員
  • 市場機會
    • 對藥物發現活動的日益關注
    • 亞太和拉丁美洲的醫療保健成長潛力
  • 市場挑戰
    • 創建複雜的人體類器官模型

波特五力戰略工具引領人類肝臟模型市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解人類肝臟模型市場的外部影響

外部宏觀環境因素在塑造人類肝臟模型市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解人體肝臟模型市場的競爭狀況

對人類肝臟模型市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣人體肝臟模型市場供應商績效評估

FPNV定位矩陣是評估人體肝臟模型市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了人類肝臟模型市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對人類肝臟模型市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 非酒精性脂肪肝盛行率上升
      • 人類肝臟疾病體外建模的新興 3D 和 2D 趨勢
      • 對肝臟類器官的努力和不斷提高的認知
    • 抑制因素
      • 缺乏熟練且訓練有素的專業人員
    • 機會
      • 增加對藥物發現活動的關注
      • 亞太和拉丁美洲的醫療保健成長潛力
    • 任務
      • 生成複雜的人體類器官模型
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章人類肝臟模型市場：依產品

  • 2D模型
  • 3D生物列印
  • 肝臟類器官

第7章人類肝臟模型市場：依應用分類

  • 藥物發現
  • 教育

第8章北美與南美人體肝臟模型市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區人體肝臟模型市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲人體肝臟模型市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • BioIVT LLC
  • Biopredic International
  • Cellink Global
  • CN Bio Innovations Ltd.
  • Emulate Inc.
  • InSphero AG
  • MIMETAS BV
  • NeurOmics, Inc.
  • Organovo Holdings Inc.
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • ZenBio, Inc.
Product Code: MRR-43127F7278DC

The Human Liver Model Market was valued at USD 2.26 billion in 2023, expected to reach USD 2.53 billion in 2024, and is projected to grow at a CAGR of 12.06%, to USD 5.03 billion by 2030.

The human liver model market encompasses the development and utilization of in vitro and in vivo models that simulate liver function for research and therapeutic purposes. These models are essential in drug discovery, pre-clinical trials, and toxicological studies due to their capability to mimic human liver responses, thereby reducing dependency on animal testing. The necessity for human liver models is driven by the rising prevalence of liver diseases, notably attributed to increasing alcohol consumption, obesity, and viral infections. Moreover, the pharmaceutical and biotechnology industries heavily employ these models to accelerate drug development pipelines and assess hepatotoxicity risks. Application extends to academic research, clinical trials, and regenerative medicine, with end-use spanning pharmaceutics, biotechnology firms, and healthcare sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 2.26 billion
Estimated Year [2024] USD 2.53 billion
Forecast Year [2030] USD 5.03 billion
CAGR (%) 12.06%

Market growth is primarily influenced by advancements in biotechnology, such as 3D bioprinting and organ-on-a-chip technologies, which offer more accurate and functional liver models. Furthermore, growing regulatory support for reducing animal testing aligns with the increasing adoption of human liver models. Potential opportunities lie in the expansion of personalized medicine and precision healthcare, where liver models could offer bespoke treatment testing. Companies should focus on enhancing the physiological relevance of these models and invest in technologies that improve scalability and reproducibility.

Despite its potential, the human liver model market faces limitations, including high initial investment costs, technical challenges in model accuracy, and the complexity of capturing all liver functions in vitro. Also, intellectual property rights and stringent regulatory standards can pose significant barriers to entry and innovation. To spur business growth, research should concentrate on refining tissue cultures and integrating artificial intelligence for predictive analytics. Continuous collaboration with regulatory bodies and investment in interdisciplinary research can further amplify market potential. The nature of the market is competitive yet ripe for innovations that enhance model reliability and applicability, presenting a fertile ground for new entrants with cutting-edge solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Liver Model Market

The Human Liver Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence rate of non-alcoholic fatty liver disease
    • Emerging 3D and 2D trends in modeling human liver disease in vitro
    • Rising initiatives and awareness about liver organoids
  • Market Restraints
    • Lack of skilled and trained professionals
  • Market Opportunities
    • Growing focus on drug discovery activities
    • Potential growth of healthcare in the Asia Pacific and Latin America
  • Market Challenges
    • Generation of complex human organoid models

Porter's Five Forces: A Strategic Tool for Navigating the Human Liver Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Liver Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Liver Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Liver Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Liver Model Market

A detailed market share analysis in the Human Liver Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Liver Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Liver Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Human Liver Model Market

A strategic analysis of the Human Liver Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Human Liver Model Market, highlighting leading vendors and their innovative profiles. These include BioIVT LLC, Biopredic International, Cellink Global, CN Bio Innovations Ltd., Emulate Inc., InSphero AG, MIMETAS B.V., NeurOmics, Inc., Organovo Holdings Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Human Liver Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across 2D Models, 3D Bio Printing, and Liver Organoids.
  • Based on Application, market is studied across Drug Discovery and Education.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence rate of non-alcoholic fatty liver disease
      • 5.1.1.2. Emerging 3D and 2D trends in modeling human liver disease in vitro
      • 5.1.1.3. Rising initiatives and awareness about liver organoids
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled and trained professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on drug discovery activities
      • 5.1.3.2. Potential growth of healthcare in the Asia Pacific and Latin America
    • 5.1.4. Challenges
      • 5.1.4.1. Generation of complex human organoid models
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Liver Model Market, by Product

  • 6.1. Introduction
  • 6.2. 2D Models
  • 6.3. 3D Bio Printing
  • 6.4. Liver Organoids

7. Human Liver Model Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Discovery
  • 7.3. Education

8. Americas Human Liver Model Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Human Liver Model Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Human Liver Model Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BioIVT LLC
  • 2. Biopredic International
  • 3. Cellink Global
  • 4. CN Bio Innovations Ltd.
  • 5. Emulate Inc.
  • 6. InSphero AG
  • 7. MIMETAS B.V.
  • 8. NeurOmics, Inc.
  • 9. Organovo Holdings Inc.
  • 10. STEMCELL Technologies Inc.
  • 11. Thermo Fisher Scientific Inc.
  • 12. ZenBio, Inc.

LIST OF FIGURES

  • FIGURE 1. HUMAN LIVER MODEL MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN LIVER MODEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HUMAN LIVER MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HUMAN LIVER MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN LIVER MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN LIVER MODEL MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 2D MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 3D BIO PRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY LIVER ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. HUMAN LIVER MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. HUMAN LIVER MODEL MARKET, FPNV POSITIONING MATRIX, 2023